Outcomes of Short-Term Tigecycline-Containing Regimens for Mycobacterium abscessus Pulmonary Disease

Sae Rom Kim; Myunghwa Jang; Su Young Kim; Dae Hun Kim; Byung Woo Jhun

doi:10.1128/aac.00774-22

Outcomes of Short-Term Tigecycline-Containing Regimens for Mycobacterium abscessus Pulmonary Disease

Sae Rom Kim
, Myunghwa Jang
, Su Young Kim
, Dae Hun Kim
, Byung Woo Jhun

Department of Internal Medicine

Sungkyunkwan University

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Short-term intravenous tigecycline therapy during a 1-month initial phase may improve early microbiological response in patients with Mycobacterium abscessus pulmonary disease (PD). However, short-term use of tigecycline did not improve the long-term culture conversion rate of M. abscessus PD. Further studies on the efficacy of prolonged intravenous tigecycline-containing regimens are needed.

Original language	English
Journal	Antimicrobial Agents and Chemotherapy
Volume	66
Issue number	10
DOIs	https://doi.org/10.1128/aac.00774-22
State	Published - Oct 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Mycobacterium abscessus
tigecycline
treatment

Access to Document

10.1128/aac.00774-22

Cite this

@article{9d8af8998daf4727b7a599e7f447d4a3,

title = "Outcomes of Short-Term Tigecycline-Containing Regimens for Mycobacterium abscessus Pulmonary Disease",

abstract = "Short-term intravenous tigecycline therapy during a 1-month initial phase may improve early microbiological response in patients with Mycobacterium abscessus pulmonary disease (PD). However, short-term use of tigecycline did not improve the long-term culture conversion rate of M. abscessus PD. Further studies on the efficacy of prolonged intravenous tigecycline-containing regimens are needed.",

keywords = "Mycobacterium abscessus, tigecycline, treatment",

author = "Kim, \{Sae Rom\} and Myunghwa Jang and Kim, \{Su Young\} and Kim, \{Dae Hun\} and Jhun, \{Byung Woo\}",

year = "2022",

month = oct,

doi = "10.1128/aac.00774-22",

language = "English",

volume = "66",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "10",

}

TY - JOUR

T1 - Outcomes of Short-Term Tigecycline-Containing Regimens for Mycobacterium abscessus Pulmonary Disease

AU - Kim, Sae Rom

AU - Jang, Myunghwa

AU - Kim, Su Young

AU - Kim, Dae Hun

AU - Jhun, Byung Woo

PY - 2022/10

Y1 - 2022/10

N2 - Short-term intravenous tigecycline therapy during a 1-month initial phase may improve early microbiological response in patients with Mycobacterium abscessus pulmonary disease (PD). However, short-term use of tigecycline did not improve the long-term culture conversion rate of M. abscessus PD. Further studies on the efficacy of prolonged intravenous tigecycline-containing regimens are needed.

AB - Short-term intravenous tigecycline therapy during a 1-month initial phase may improve early microbiological response in patients with Mycobacterium abscessus pulmonary disease (PD). However, short-term use of tigecycline did not improve the long-term culture conversion rate of M. abscessus PD. Further studies on the efficacy of prolonged intravenous tigecycline-containing regimens are needed.

KW - Mycobacterium abscessus

KW - tigecycline

KW - treatment

UR - https://www.scopus.com/pages/publications/85140270730

U2 - 10.1128/aac.00774-22

DO - 10.1128/aac.00774-22

M3 - Article

C2 - 36165626

AN - SCOPUS:85140270730

SN - 0066-4804

VL - 66

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 10

ER -

Outcomes of Short-Term Tigecycline-Containing Regimens for Mycobacterium abscessus Pulmonary Disease

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this